Exelixis, Inc. (EXEL) has a market capitalization of $12.3B and trades at $45.86. The 52-week range is 32.38-49.62.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 15.9, Earnings Per Share (EPS) of $2.88, annual revenue of $2.32B.
The stock has a beta of 0.42, operates in the Healthcare sector.
